Hey Rick (or Thalio or someone), maybe you can answer the question I posed to scooby ... what is the downside to having some large pharma take over the corp. Or, for that matter where do we investors get hurt by a take-over, hostile or not? Seems that only those in management would stand to lose anything, and wouldn't a large outfit bring the financial expertise and resources that we seem to need?
Do you think that the increase in shares is primarily to prevent such a take over? Do you see that announcement of the desire to increase the share authorization as a factor in the recent price drop?
BTW, I drove by 3100 Wilcrest ... nice digs. They are just as easy to get to as the old ones ... a little closer to I-10. Was any reason ever offered for the move in the first place?